Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Undisclosed EGFR/B7H3 CAR-T

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Guangzhou Medical University, Hedy Group

Drug class:

B7-H3-targeted CAR-T immunotherapy, EGFR-targeted CAR-T immunotherapy

Related drugs:

‹

›